The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL

Erstveröffentlichung
2017Authors
Savino, Angela Maria
Sarno, Jolanda
Trentin, Luca
Vieri, Margherita
Fazio, Grazia
Wissenschaftlicher Artikel
Published in
Leukemia ; 31 (2017), 11. - S. 2365-2375. - ISSN 0887-6924. - eISSN 1476-5551
Link to publication
https://dx.doi.org/10.1038/leu.2017.93Institutions
UKU. Klinik für Kinder- und JugendmedizinSubject headings
[Free subject headings]: acute lymphoblastic-leukemia | childrens oncology group | myeloproliferative neoplasms | xenograft models | downs-syndrome | 1st relapse | jak2 | crlf2 | receptor | resistance[DDC subject group]: DDC 610 / Medicine & health